Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Vaccine. 2015 Jun 12;33(26):2963-7. doi: 10.1016/j.vaccine.2015.04.087. Epub 2015 May 7.

The effect of BCG on iron metabolism in the early neonatal period: A controlled trial in Gambian neonates.

Author information

1
Department of Clinical Research London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Electronic address: sarah.prentice@lshtm.ac.uk.
2
MRC International Nutrition Group, MRC Keneba, The Gambia. Electronic address: mwjallow@mrc.gm.
3
MRC International Nutrition Group, MRC Keneba, The Gambia. Electronic address: Andrew.prentice@lshtm.ac.uk.

Abstract

Bacillus Calmette-Guerin (BCG) vaccination has been reported to protect neonates from non-tuberculous pathogens, but no biological mechanism to explain such effects is known. We hypothesised that BCG produces broad-spectrum anti-microbial protection via a hepcidin-mediated hypoferraemia, limiting iron availability for pathogens. To test this we conducted a trial in 120 Gambian neonates comparing iron status in the first 5-days of life after allocation to: (1) All routine vaccinations at birth (BCG/Oral Polio Vaccine (OPV)/Hepatitis B Vaccine (HBV)); (2) BCG delayed until after the study period (at day 5); and (3) All routine vaccinations delayed until after the study period. Vaccine regime at birth did not significantly impact on any measured parameter of iron metabolism. However, the ability to detect an effect of BCG on iron metabolism may have been limited by short follow-up time and high activation of the inflammatory-iron axis in the study population.

KEYWORDS:

BCG; Hepcidin; Heterologous effects; ISRCTN93854442; Iron; Neonate

PMID:
25959747
PMCID:
PMC4503799
DOI:
10.1016/j.vaccine.2015.04.087
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center